PD L1 News and Research

RSS
CRI, MedImmune partner to advance cancer immunotherapy research

CRI, MedImmune partner to advance cancer immunotherapy research

New results describe development of DC cancer vaccine with enhanced immunogenic potential

New results describe development of DC cancer vaccine with enhanced immunogenic potential

Antibody that blocks programmed cell death benefits cancer patients

Antibody that blocks programmed cell death benefits cancer patients

Interim results from Bristol-Myers Squibb’s BMS-936558 Phase 1 study on NSCLC, MM and RCC

Interim results from Bristol-Myers Squibb’s BMS-936558 Phase 1 study on NSCLC, MM and RCC

Study supports wider testing for immune-based therapies to treat advanced non-small cell lung cancer

Study supports wider testing for immune-based therapies to treat advanced non-small cell lung cancer

A melanoma cloaking protein

A melanoma cloaking protein

Melanomas express B7-H1 protein to hide from T-cells

Melanomas express B7-H1 protein to hide from T-cells

Genetically engineered pigs may help overcome donor organ shortage

Genetically engineered pigs may help overcome donor organ shortage

New gene therapy may cure Type 1 diabetes

New gene therapy may cure Type 1 diabetes

Medarex starts phase 1b clinical trial with MDX-1106 for the treatment of cancer

Medarex starts phase 1b clinical trial with MDX-1106 for the treatment of cancer

Chronic infection persists by targeting stromal cell network in lymphoid organs

Chronic infection persists by targeting stromal cell network in lymphoid organs

Tumors use enzyme to recruit regulatory T-cells and suppress immune response

Tumors use enzyme to recruit regulatory T-cells and suppress immune response

Gene discovery may reinvigorate the body's immune system after fighting viral infections

Gene discovery may reinvigorate the body's immune system after fighting viral infections